Pathway-based Screening
Pathway-Based Screening is a phenotypic screening approach that identifies bioactive compounds or genetic perturbations by assessing their effects on predefined biological pathways rather than on individual molecular targets or gross cellular phenotypes.
41
Publications
1.3K
Citations
310
Authors
119
Institutions
Publications per year
2017–2026
12
Parents
41
Breast cancer risk, nightwork, and circadian clock gene polymorphisms
Thérèse Truong, Benoît Liquet, F. Ménégaux et al. · Endocrine Related Cancer · 2014 · 87 citations · Full text
Life Sciences, Genetics, Oncology +17
Genetic and environmental pathways to complex diseases
Julia M. Gohlke, Reuben Thomas, Yonqing Zhang et al. · BMC Systems Biology · 2009 · 76 citations · Full text
1–5 of 41
310
2
h-index
1
h-index
Chinese Academy of Medical Sciences & Peking Union Medical College, China
1 publications · 19 citations
1
h-index
1
h-index
1
h-index
1–5 of 310
119

Research Triangle Park Foundation
Durham, United States
5 h-index
16 publications
338 citations
National Institutes of Health
Bethesda, United States
2 h-index
10 publications
256 citations
University of Pittsburgh
Pittsburgh, United States
2 h-index
13 publications
923 citations
Duke University
Durham, United States
2 h-index
9 publications
317 citations

Chinese Academy of Sciences
Beijing, China
2 h-index
9 publications
162 citations

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
2 h-index
5 publications
117 citations
Environmental Protection Agency
Washington, United States
2 h-index
6 publications
102 citations
Inserm
Paris, France
2 h-index
13 publications
1.1K citations
1–8 of 119
2 publications · 60 citations
2
h-index
2 publications · 47 citations
2
h-index
AAC · 2 publications · 108 citations
2
h-index
2 publications · 37 citations
2
h-index
MJA · 1 publications · 43 citations
1
h-index
1–5